コンテンツへスキップ
Merck
  • Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7.

Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7.

Journal of virology (2010-10-29)
Monika Oldak, Liv Tolzmann, Artur Wnorowski, Marta Justyna Podgórska, Steffi Silling, Rongtuan Lin, John Hiscott, Cornelia Sigrid Lissi Müller, Thomas Vogt, Hans Smola, Sigrun Smola
要旨

The genus β human papillomavirus (HPV) type 8 is associated with nonmelanoma skin cancer in patients with epidermodysplasia verruciformis, and evidence for its protumorigenic potential in the general population increases. To date, strategies to suppress genus β HPV infections are limited. Interferon regulatory factors IRF-3 and IRF-7 play key roles in the activation of the innate immune response to viral infections. In this study, we show for the first time that both IRF-3 and IRF-7 regulate transcription of a papillomavirus, but with opposing effects. IRF-7, expressed in the suprabasal layers of human epidermis, increased HPV8 late promoter activity via direct binding to viral DNA. UV-B light-induced activation of the HPV8 promoter involved IRF-7 as a downstream effector. In contrast, IRF-3, expressed in all layers of human epidermis, induced strong HPV8 suppression in primary keratinocytes. IRF-3-mediated suppression prevailed over IRF-7-induced HPV8 transcription. Unlike the E6 oncoprotein of the mucosal high-risk HPV16, the HPV8 E6 protein did not bind to IRF-3 and only weakly antagonized its activity. Strong antiviral activity was also observed, when keratinocytes were treated with potent IRF-3 activators, poly(I:C) or RNA bearing 5' phosphates. In conclusion, we show that IRF-3 activation induces a state of cell-autonomous immunity against HPV in primary human keratinocytes. Our study suggests that local application of IRF-3-activating compounds might constitute an attractive novel therapeutic strategy against HPV8-associated diseases, particularly in epidermodysplasia verruciformis patients.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
モノクローナル抗FLAG® M5 マウス宿主抗体, clone M5, purified immunoglobulin, buffered aqueous solution